X842 Placebo: Clinical Trials

2 trials of X842 Placebo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow X842 Placebo: new trials by email Literature Review of X842 Placebo trials Research Report on X842 Placebo

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Phase III Clinical Trial of X842 Capsules for Reflux Esophagitis
X842, X842 Placebo, Lansoprazole - Reflux Esophagitis
Phase 3CompletedJiangsu Sinorda Biomedicine Co., Ltd3802021-06-242025-07-23
Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis
X842, X842 Placebo, Lansoprazole - Reflux Esophagitis
Phase 2CompletedJiangsu Sinorda Biomedicine Co., Ltd902020-01-212025-07-17

Conditions studied

Esophagitis, Peptic (2)  ·  Gastroesophageal Reflux (1)

Sponsors

Jiangsu Sinorda Biomedicine Co., Ltd (2)

Countries

China (2)

Top investigators

Pingsheng Hu, Ph.D (2)

Results publications

PMID 39836012